Rizavasertib (Standard) is the analytical standard of Rizavasertib ( HY-10425 ). This product is intended for research and analytical applications. A-443654 is a pan-Akt inhibitor and has equal potency against Akt1 , Akt2 , or Akt3 within cells (Ki=160 pM).
Products | Products > Signaling Pathways > Others | Products > Signaling Pathways > PI3K/Akt/mTOR | Products > Research Areas > Cancer | Products > Research Areas > Cancer > Cancer Targeted Therapy | Products > Research Areas > Cancer > Cancer Metabolism and Metastasis | Products > Signaling Pathways > Reference Standards | Products > Signaling Pathways > Akt
Please leave a message for us or use the following ways to contact us, we will reply to you as soon as possible, and provide you with the most sincere service, thank you.